Plasmid DNA production for pharmaceutical use: role of specific growth rate and impact on process design.
about
Plasmid pVAX1-NH36 purification by membrane and bead perfusion chromatography.Segregated growth kinetics of Escherichia coli DH5α-NH36 in exponential-fed perfusion culture for pDNA vaccine production.Plasmid DNA primary recovery from E. coli lysates by depth bed microfiltration.Physiological effects of pH gradients on Escherichia coli during plasmid DNA production.Optimization of fermentation conditions for an strain engineered using the response surface method to produce a novel therapeutic DNA vaccine for rheumatoid arthritis
P2860
Plasmid DNA production for pharmaceutical use: role of specific growth rate and impact on process design.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Plasmid DNA production for pha ...... and impact on process design.
@en
Plasmid DNA production for pha ...... and impact on process design.
@nl
type
label
Plasmid DNA production for pha ...... and impact on process design.
@en
Plasmid DNA production for pha ...... and impact on process design.
@nl
prefLabel
Plasmid DNA production for pha ...... and impact on process design.
@en
Plasmid DNA production for pha ...... and impact on process design.
@nl
P2860
P356
P1476
Plasmid DNA production for pha ...... and impact on process design.
@en
P2860
P304
P356
10.1002/BIT.23138
P577
2011-05-24T00:00:00Z